This ETF is trying to satisfy appetites for weight loss stocks
Tema ETFs is behind the GLP-1, Obesity & Cardiometabolic ETF (HRTS), which is up 26% since its inception last November.
Read More
Health care industry
Investors want proof AI will aid drug discovery. Evidence may come in the second half
Nvidia is a fan of Recursion Pharmaceuticals. Data expected from the company will help determine valuations for stocks using AI
Read More
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
Novo Nordisk investors appeared unperturbed Thursday by a critical Harvard report that linked weight loss drugs to a rare eye
Read More
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
It's a long-awaited win for Eli Lilly after donanemab faced several delays in its path to the market, including an
Read More
Rite Aid bankruptcy plan approved, cutting $2 billion in debt
Rite Aid used its bankruptcy to close hundreds of stores, sell its pharmacy benefit company Elixir, and negotiate settlements. Source
Read More
Marketplace health insurance may get more expensive — unless Congress extends this tax break
The premium tax credit, which makes marketplace health insurance premiums more affordable, could become less generous after 2025. Here's what
Read More
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Drugmakers showed off data on weight loss and diabetes drugs. Also, Oracle announced the general availability of AI documentation assistant
Read More
Biden administration to lower costs for 64 drugs through inflation penalties on drugmakers
President Joe Biden has made lowering U.S. drug prices a key pillar of his health-care agenda and reelection platform for
Read More
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
The new plant in Clayton, North Carolina, will be responsible for filling and packaging syringes and injection pens for Wegovy,
Read More